Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Lenz

Showing results (31-40 of 294) with videos related to

Pageof 30
Sort By:
Annals of Hematology|August 17, 2004
Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemiaGeorg Lenz, Grit Hutter, Wolfgang Hiddemann, et al.
Leukemia & Lymphoma|July 28, 2010
Prognostic biomarkers in malignant lymphomasRandy D Gascoyne, Andreas Rosenwald, Sibrand Poppema, et al.
British Journal of Haematology|January 24, 2018
Ibrutinib resistance in mantle cell lymphoma: clinical, molecular and treatment aspectsOshrat Hershkovitz-Rokah, Dana Pulver, Georg Lenz, et al.
British Journal of Haematology|October 28, 2024
Sequencing of therapy for patients with diffuse large B-cell lymphoma in the era of novel drugsImke E Karsten, Evgenii Shumilov, Norbert Schmitz, et al.
Annals of Hematology|August 10, 2021
Vaccine-induced pseudothrombocytopenia after Ad26.COV2.S vaccinationMarcel Kemper, Christoph Berssenbrügge, Georg Lenz, et al.
Blood|October 22, 2003
Epstein-Barr virus-associated B-cell non-Hodgkin lymphoma following treatment of hairy cell leukemia with cladribineGeorg Lenz, Alexander Golf, Thomas Rüdiger, et al.
Cancers|July 12, 2025
Redefining the Fight Against SCLC: Standards, Innovations, and New HorizonsMarcel Kemper, Lea Elisabeth Reitnauer, Georg Lenz, et al.
Seminars in Hematology|July 26, 2011
The use of microarray technologies in mantle cell lymphomaBoris A Ratsch, Michael Grau, Bernd Dörken, et al.
Anti-Cancer Drugs|October 11, 2003
Adverse reactions to oxaliplatin: a retrospective study of 25 patients treated in one institutionGeorg Lenz, Ulrich T Hacker, Wolfgang Kern, et al.
Leukemia & Lymphoma|November 30, 2016
The molecular pathogenesis of mantle cell lymphomaNiklas Vogt, Beiying Dai, Tabea Erdmann, et al.
Pageof 30

Showing results (31-40 of 294) with videos related to

Sort By:
Pageof 30
Annals of Hematology|August 17, 2004
Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemiaGeorg Lenz, Grit Hutter, Wolfgang Hiddemann, et al.
Leukemia & Lymphoma|July 28, 2010
Prognostic biomarkers in malignant lymphomasRandy D Gascoyne, Andreas Rosenwald, Sibrand Poppema, et al.
British Journal of Haematology|January 24, 2018
Ibrutinib resistance in mantle cell lymphoma: clinical, molecular and treatment aspectsOshrat Hershkovitz-Rokah, Dana Pulver, Georg Lenz, et al.
British Journal of Haematology|October 28, 2024
Sequencing of therapy for patients with diffuse large B-cell lymphoma in the era of novel drugsImke E Karsten, Evgenii Shumilov, Norbert Schmitz, et al.
Annals of Hematology|August 10, 2021
Vaccine-induced pseudothrombocytopenia after Ad26.COV2.S vaccinationMarcel Kemper, Christoph Berssenbrügge, Georg Lenz, et al.
Blood|October 22, 2003
Epstein-Barr virus-associated B-cell non-Hodgkin lymphoma following treatment of hairy cell leukemia with cladribineGeorg Lenz, Alexander Golf, Thomas Rüdiger, et al.
Cancers|July 12, 2025
Redefining the Fight Against SCLC: Standards, Innovations, and New HorizonsMarcel Kemper, Lea Elisabeth Reitnauer, Georg Lenz, et al.
Seminars in Hematology|July 26, 2011
The use of microarray technologies in mantle cell lymphomaBoris A Ratsch, Michael Grau, Bernd Dörken, et al.
Anti-Cancer Drugs|October 11, 2003
Adverse reactions to oxaliplatin: a retrospective study of 25 patients treated in one institutionGeorg Lenz, Ulrich T Hacker, Wolfgang Kern, et al.
Leukemia & Lymphoma|November 30, 2016
The molecular pathogenesis of mantle cell lymphomaNiklas Vogt, Beiying Dai, Tabea Erdmann, et al.
Pageof 30